| Official American thoracic society/centers for disease control and prevention/infectious diseases society of America clinical practice guidelines: treatment of drug-susceptible … P Nahid, SE Dorman, N Alipanah, PM Barry, JL Brozek, A Cattamanchi, ... Clinical infectious diseases 63 (7), e147-e195, 2016 | 1562 | 2016 |
| Towards tuberculosis elimination: an action framework for low-incidence countries K Lönnroth, GB Migliori, I Abubakar, L D'Ambrosio, G De Vries, R Diel, ... European Respiratory Journal 45 (4), 928-952, 2015 | 870 | 2015 |
| Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis JA Caminero, G Sotgiu, A Zumla, GB Migliori The Lancet infectious diseases 10 (9), 621-629, 2010 | 770 | 2010 |
| Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis M Sester, G Sotgiu, C Lange, C Giehl, E Girardi, GB Migliori, A Bossink, ... European Respiratory Journal 37 (1), 100-111, 2011 | 748 | 2011 |
| Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients SD Ahuja, D Ashkin, M Avendano, R Banerjee, M Bauer, JN Bayona, ... Public Library of Science 9 (8), e1001300, 2012 | 740 | 2012 |
| Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries H Getahun, A Matteelli, I Abubakar, MA Aziz, A Baddeley, D Barreira, ... European Respiratory Journal 46 (6), 1563-1576, 2015 | 717 | 2015 |
| Control of confounding and reporting of results in causal inference studies. Guidance for authors from editors of respiratory, sleep, and critical care journals DJ Lederer, SC Bell, RD Branson, JD Chalmers, R Marshall, DM Maslove, ... Annals of the American Thoracic Society 16 (1), 22-28, 2019 | 622 | 2019 |
| The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement I Solovic, M Sester, JJ Gomez-Reino, HL Rieder, S Ehlers, HJ Milburn, ... European Respiratory Journal 36 (5), 1185-1206, 2010 | 593 | 2010 |
| Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis N Ahmad, SD Ahuja, OW Akkerman, JWC Alffenaar, LF Anderson, ... The Lancet 392 (10150), 821-834, 2018 | 531 | 2018 |
| Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases M Tadolini, LR Codecasa, JM García-García, FX Blanc, S Borisov, ... European Respiratory Journal 56 (1), 2020 | 504 | 2020 |
| Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes D Falzon, N Gandhi, GB Migliori, G Sotgiu, HS Cox, TH Holtz, ... European Respiratory Journal 42 (1), 156-168, 2013 | 499 | 2013 |
| Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis G Sotgiu, R Centis, L D'Ambrosio, JWC Alffenaar, HA Anger, JA Caminero, ... European Respiratory Journal 40 (6), 1430-1442, 2012 | 495 | 2012 |
| Treatment of drug-resistant tuberculosis. An official ATS/CDC/ERS/IDSA clinical practice guideline P Nahid, SR Mase, GB Migliori, G Sotgiu, GH Bothamley, JL Brozek, ... American journal of respiratory and critical care medicine 200 (10), e93-e142, 2019 | 437 | 2019 |
| Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR-and XDR-TB: a multicentre study SE Borisov, K Dheda, M Enwerem, RR Leyet, L D'Ambrosio, R Centis, ... European Respiratory Journal 49 (5), 2017 | 377 | 2017 |
| Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis GB Migliori, G Sotgiu, NR Gandhi, D Falzon, K DeRiemer, R Centis, ... European Respiratory Journal 42 (1), 169-179, 2013 | 327 | 2013 |
| European union standards for tuberculosis care GB Migliori, JP Zellweger, I Abubakar, E Ibraim, JA Caminero, G De Vries, ... European Respiratory Journal 39 (4), 807-819, 2012 | 293 | 2012 |
| Tuberculosis and COVID-19 interaction: a review of biological, clinical and public health effects D Visca, CWM Ong, S Tiberi, R Centis, L D’ambrosio, B Chen, J Mueller, ... Pulmonology 27 (2), 151-165, 2021 | 291 | 2021 |
| Clinical phenotypes in adult patients with bronchiectasis S Aliberti, S Lonni, S Dore, MJ McDonnell, PC Goeminne, K Dimakou, ... European Respiratory Journal 47 (4), 1113-1122, 2016 | 291 | 2016 |
| A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis GB Migliori, B Eker, MD Richardson, G Sotgiu, JP Zellweger, A Skrahina, ... European Respiratory Journal 34 (2), 387-393, 2009 | 272 | 2009 |
| Characterization of the “frequent exacerbator phenotype” in bronchiectasis JD Chalmers, S Aliberti, A Filonenko, M Shteinberg, PC Goeminne, ... American journal of respiratory and critical care medicine 197 (11), 1410-1420, 2018 | 264 | 2018 |
